These pages provide visibility to Repligen news, SEC filings, financial and other information that may factor into an investment decision. We welcome your questions or comments.   

investors@repligen.com

Press Releases

Search Press Releases
  
Subscribe for Email Alerts
4/29/2016
11:24 AM ET
Press Release

Repligen to Report First Quarter 2016 Financial Results

4/29/2016

WALTHAM, Mass., April 29, 2016 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report first quarter 2016 financial results on Thursday, May 5, 2016. The...

 Continue Reading
4/4/2016
7:30 AM ET
Press Release

Repligen Acquires Atoll GmbH

4/4/2016

WALTHAM, Mass., April 04, 2016 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has acquired At...

 Continue Reading
3/31/2016
8:46 AM ET
Press Release

Repligen Forms Scientific Advisory Board

3/31/2016

WALTHAM, Mass., March 31, 2016 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced its formation of a Scie...

 Continue Reading
2/25/2016
7:30 AM ET
Earnings Release

Repligen Reports Fourth Quarter and Year 2015 Financial Results

2/25/2016

- Constant currency revenue growth of 45% for the fourth quarter, 47% for the year -- Gross margin expansion of 420 basis points to 57.8% for the year -- Non-GAAP adjusted EPS of $0.40, an increase of...

 Continue Reading
2/24/2016
4:59 PM ET
Press Release

Repligen Announces Extension of Long Term Supply Agreement for Protein A

2/24/2016

WALTHAM, Mass., Feb. 24, 2016 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that it has extended through 2019 a key long-term supply agreement with GE Healthcare for the man...

 Continue Reading
Displaying 1 to 5 (of 173 releases)
Copyright 2016, © SNL Financial LC  Terms of Use